Childhood leukemias in Mexico: towards implementing CAR-T cell therapy programs
Leukemias are the most common type of pediatric cancer around the world. Prognosis has improved during the last decades, and many patients are cured with conventional treatment as chemotherapy; however, many patients still present with a refractory disease requiring additional treatments, including...
Main Authors: | Juan Carlos Bustamante-Ogando, Alejandrina Hernández-López, César Galván-Díaz, Roberto Rivera-Luna, Hugo E. Fuentes-Bustos, Angélica Meneses-Acosta, Alberto Olaya-Vargas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1304805/full |
Similar Items
-
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia
by: Adriana Seber, et al.
Published: (2021-11-01) -
CAR T-cells for T-cell acute lymphoblastic leukemia
by: Marie Emilie Dourthe, et al.
Published: (2024-06-01) -
A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
by: Pranav Puri, BA, et al.
Published: (2021-02-01) -
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia
by: Mark Gurney, et al.
Published: (2021-03-01) -
Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
by: Claudia Rossig, et al.
Published: (2018-11-01)